EGFR-Targeted Cellular Delivery of Therapeutic Nucleic Acids Mediated by Boron Clusters

New boron carriers with high boron content and targeted cancer-cell delivery are considered the first choice for boron neutron capture therapy (BNCT) for cancer treatment. Previously, we have shown that composites of antisense oligonucleotide and boron clusters are functional nanoparticles for the d...

Descripción completa

Detalles Bibliográficos
Autores principales: Kaniowski, Damian, Suwara, Justyna, Ebenryter-Olbińska, Katarzyna, Jakóbik-Kolon, Agata, Nawrot, Barbara
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9740766/
https://www.ncbi.nlm.nih.gov/pubmed/36499115
http://dx.doi.org/10.3390/ijms232314793

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9740766/
https://www.ncbi.nlm.nih.gov/pubmed/36499115
http://dx.doi.org/10.3390/ijms232314793

Ejemplares similares